Temperature-controlled supply chain solutions firm Cryoport has registered all three of its MVE Biological Solutions (MVE) manufacturing facilities with the US Food and Drug Administration (FDA).
A Cryoport company that specialises in cryogenic freezers and dewars, MVE has manufacturing locations in Ball Ground in Georgia, New Prague in Minnesota, and Chengdu in China.
In addition to the locations, all applicable MVE-manufactured cryogenic freezers and dewars are now also listed with the FDA.
Jerrell Shelton, CEO of Cryoport, said the news highlights the company’s commitment to delivering high-quality and reliable supply chain solutions for the life sciences industry.
... to continue reading you must be subscribed
